- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05490927
Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults
May 21, 2025 updated by: Brooke Kauffman, University of Houston
Latinx Smokers: Evaluating Ethnic Microaggressions on Smoking Behavior and Relapse
The purpose of this study is to examine whether microaggressions relate to multimodal facets of smoking behavior, subjective withdrawal, and urge/craving.
Additionally, the second aim is to examine whether smoking deprivation moderates the relation between microaggressions and multiple facets of smoking behavior, subjective withdrawal, and urge/craving.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This proposal will employ a novel multi-modal approach to evaluate the role of microaggressions in relation to smoking lapse and topography among a sample of Latinx smokers.
Adult Latinx daily smokers will attend two counterbalanced experimental sessions - (1) smoking deprivation (16 hours of smoking abstinence) and (2) smoking as usual - during which microaggressions during the relapse analog task will be assessed.
Study Type
Interventional
Enrollment (Estimated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Brooke Y Kauffman, Ph.D.
- Phone Number: (713) 743-8056
- Email: bkauffma@central.uh.edu
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77204
- Recruiting
- RESTORE Laboratory: Research on Emotion, Substance Treatment Outcomes, and Racial Equity
-
Contact:
- Aniqua Salwa, B.A.
- Phone Number: 713-743-8056
- Email: asalwa@central.uh.edu
-
Principal Investigator:
- Brooke Kauffman, Ph.D.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Being 18 years of age or older
- Current regular (daily) cigarette smoking for >= 1 year
- Current smoking >= 5 cig/day and biochemically confirmed via carbon monoxide (CO) analysis
- Being self-identified as Hispanic or Latino
- Able to provide written, informed consent
- Endorsement of at least one microaggression experience over the past 6-months
Exclusion Criteria:
- Endorsement of current psychotic symptoms
- Active suicidality
- Currently pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Smoking Deprivation
16 hours of smoking abstinence prior to experimental visit.
|
Participants will engage in a microaggression recall task followed by the McKee Experimental Relapse Analogue Task
|
|
Experimental: Smoking as Usual
Smoking as usual prior to experimental visit.
|
Participants will engage in a microaggression recall task followed by the McKee Experimental Relapse Analogue Task
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Smoking Behaviors
Time Frame: During the Smoking as Usual Visit and Smoking Deprivation Visit (Visits are randomly ordered, counterbalanced separated by ~14 days)
|
Smoking behaviors will be operationally defined as smoking topography (e.g., puff behavior) measured via the Clinical Research Support System (CReSS; Plowshare Technologies, Borgwaldt KC, Inc., Virginia).
|
During the Smoking as Usual Visit and Smoking Deprivation Visit (Visits are randomly ordered, counterbalanced separated by ~14 days)
|
|
Subjective Withdrawal
Time Frame: During the Smoking as Usual Visit and Smoking Deprivation Visit (Visits are randomly ordered, counterbalanced separated by ~14 days)
|
The 8-item Minnesota Withdrawal Scale will be used to assesses withdrawal severity.
Each of the items are rated on a Likert-type scale ranging from 0 to 4. Items are summed to produce a total score with higher scores indicative of worse outcomes (possible range 0-32).
|
During the Smoking as Usual Visit and Smoking Deprivation Visit (Visits are randomly ordered, counterbalanced separated by ~14 days)
|
|
Urge/Craving
Time Frame: During the Smoking as Usual Visit and Smoking Deprivation Visit (Visits are randomly ordered, counterbalanced separated by ~14 days)
|
Smoking urge/craving will be measured with the 10-item Questionnaire of Smoking Urges-Brief (QSU-B).
Each of the items are rated on a Likert-type scale ranging from 1 to 7. Items are summed to create two subscale scores and a total score with higher scores indicative of worse outcomes (possible range 7-70).
|
During the Smoking as Usual Visit and Smoking Deprivation Visit (Visits are randomly ordered, counterbalanced separated by ~14 days)
|
|
Smoking Lapse Behaviors
Time Frame: During the Smoking as Usual Visit and Smoking Deprivation Visit (Visits are randomly ordered, counterbalanced separated by ~14 days)
|
Smoking Lapse Behaviors will be measured during the Relapse Analogue Task (RAT), during which participants are able to delay smoking for a small financial reward.
For this task, Smoking Lapse Behaviors are conceptualized as two variables: (a) minutes in time of smoking delay (possible range -50 to +50) and (b) number of cigarettes smoked
|
During the Smoking as Usual Visit and Smoking Deprivation Visit (Visits are randomly ordered, counterbalanced separated by ~14 days)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Brooke Y Kauffman, Ph.D., University of Houston
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 13, 2022
Primary Completion (Estimated)
July 31, 2025
Study Completion (Estimated)
July 31, 2025
Study Registration Dates
First Submitted
June 17, 2022
First Submitted That Met QC Criteria
August 4, 2022
First Posted (Actual)
August 8, 2022
Study Record Updates
Last Update Posted (Actual)
May 28, 2025
Last Update Submitted That Met QC Criteria
May 21, 2025
Last Verified
May 1, 2025
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
University GhentActive, not recruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Johns Hopkins UniversityNational Center for Advancing Translational Sciences (NCATS); Community Partnership...CompletedSmoking Cessation | Smoking Reduction | Smoking, TobaccoUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Completed
-
Ghana Health ServicesKwame Nkrumah University of Science and TechnologyNot yet recruitingSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking Behaviors
Clinical Trials on Microaggression Recall and Relapse Analogue Task
-
Zealand University HospitalDemensAI ApS (private tech partner, Denmark)Not yet recruitingStress | Cognitive Impairment | Mild Cognitive Impairment (MCI) | Lewy Body Dementia (LBD) | Frontotemporal Dementia (FTD) | Alzheimer Dementia (AD) | Depression - Major Depressive Disorder | Vascular Dementia (VaD) | Dementia (Diagnosis)Denmark
-
KU LeuvenUniversitaire Ziekenhuizen KU LeuvenNot yet recruitingChemotherapy-Induced Peripheral Neuropathy | CIPN - Chemotherapy-Induced Peripheral Neuropathy | Chemotherapy-Induced Peripheral Neuropathy in Breast CancerBelgium
-
Glenn-Milo SantosNational Institute on Drug Abuse (NIDA)Terminated